PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs

Celine J Van De Laar,Celine J Van De Laar,Martijn A H Oude Voshaar,Peter Ten Klooster,Peter Ten Klooster,Danyta I Tedjo,Reinhard Bos,Tim Jansen,A Willemze,Grada A Versteeg,Y P M Goekoop-Ruiterman,Eric-Jan Kroot,Mart Van De Laar,Mart Van De Laar

doi:10.1136/rmdopen-2024-004291

PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs

Celine J Van De Laar, Celine J Van De Laar + Show 12 more

Open Access

https://doi.org/10.1136/rmdopen-2024-004291

Copy DOI

Journal: RMD Open	Publication Date: May 30, 2024
License type: cc-by-nc

#Changes In Patient-reported Outcome Measures #TNF Inhibitors In Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveTo compare the effectiveness of a strategy administering baricitinib versus one using TNF-inhibitors (TNFi) in patients with rheumatoid arthritis (RA) after conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) failure in a...

Full Text